Gaelic Laboratories
Private Company
Funding information not available
Overview
Gaelic Laboratories is a newly established but strategically positioned CDMO focusing exclusively on the niche Beta-Lactam antibiotic sector. Leveraging a pre-existing, HPRA-licensed facility in Ireland with a 40-year manufacturing history, the company provides end-to-end services from API handling to finished product packaging and full regulatory support. Its dual strategy involves contract manufacturing for third parties and the future commercialisation of its own generic Gaelic Laboratories-branded products, targeting growth in Europe and the emerging MENA markets.
Technology Platform
Dedicated, HPRA-licensed manufacturing and analytical infrastructure for Beta-Lactam antibiotics, offering integrated services from method development to regulatory batch release.
Opportunities
Risk Factors
Competitive Landscape
Gaelic Laboratories competes with large, diversified CDMOs (e.g., Lonza, Catalent) and established generic pharmaceutical manufacturers with in-house Beta-Lactam capacity. Its niche specialization and EU-licensed site are differentiators, but it faces competition on cost, scale, and global reach from larger players and regional manufacturers in target markets.